Editorial inquiries

What we can respond to

Retatrutide Telehealth Digest is a documentation project. Welcome here:

• Corrections — a factual error, an outdated citation, or a claim that doesn't match its source. Describe it specifically; it will be reviewed and updated.
• Citation suggestions — a relevant peer-reviewed study missing from the documented record.
• Editorial feedback — questions about framing, editorial choices, or how the record is characterized.

Every submission is reviewed and the record updated when a correction is warranted. Not every inquiry gets a reply.

What we cannot respond to

This is not a medical service, and no one here is a clinician. It cannot and does not:

• Advise whether retatrutide is appropriate for any individual.
• Recommend sources, vendors, or suppliers.
• Answer questions about dosing, reconstitution, or self-administration.
• Provide medical referrals.
• Respond to inquiries that assume a healthcare or telehealth service is on offer.

For medical guidance, consult a licensed healthcare provider.

Contact form

Use the form below for editorial inquiries. Give as much specific context as you can — vague feedback is hard to act on.

Subject [text field] Message [textarea] Your email (optional) [email field]

[Submit]

Retatrutide Telehealth Digest documents peer-reviewed research. It is not a clinic, pharmacy, telehealth provider, or vendor, and no medical advice is offered through this form or anywhere on the site.